AP3045A - New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it - Google Patents

New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it

Info

Publication number
AP3045A
AP3045A AP2008004380A AP2008004380A AP3045A AP 3045 A AP3045 A AP 3045A AP 2008004380 A AP2008004380 A AP 2008004380A AP 2008004380 A AP2008004380 A AP 2008004380A AP 3045 A AP3045 A AP 3045A
Authority
AP
ARIPO
Prior art keywords
agomelatine
pharmaceutical compositions
compositions containing
new association
thymoregulatory
Prior art date
Application number
AP2008004380A
Other languages
English (en)
Other versions
AP2008004380A0 (en
Inventor
Christian De Bodinat
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36190792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3045(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2008004380A0 publication Critical patent/AP2008004380A0/xx
Application granted granted Critical
Publication of AP3045A publication Critical patent/AP3045A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/08Preparation of carboxylic acid amides from amides by reaction at nitrogen atoms of carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/10Antiepileptics; Anticonvulsants for petit-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • A61P25/12Antiepileptics; Anticonvulsants for grand-mal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AP2008004380A 2005-09-09 2006-09-08 New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it AP3045A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509208A FR2890563B1 (fr) 2005-09-09 2005-09-09 Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent
PCT/FR2006/002066 WO2007028903A1 (fr) 2005-09-09 2006-09-08 Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
AP2008004380A0 AP2008004380A0 (en) 2008-04-30
AP3045A true AP3045A (en) 2014-11-30

Family

ID=36190792

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004380A AP3045A (en) 2005-09-09 2006-09-08 New association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it

Country Status (38)

Country Link
US (1) US7902180B2 (xx)
EP (2) EP1762238B1 (xx)
JP (1) JP2007077149A (xx)
KR (2) KR20070029607A (xx)
CN (1) CN1927194A (xx)
AP (1) AP3045A (xx)
AR (1) AR055418A1 (xx)
AT (1) ATE519482T1 (xx)
AU (1) AU2006209371B2 (xx)
BR (1) BRPI0603767A (xx)
CA (1) CA2558764C (xx)
CY (1) CY1112223T1 (xx)
DK (1) DK1762238T3 (xx)
EA (1) EA014381B1 (xx)
ES (1) ES2371482T3 (xx)
FR (1) FR2890563B1 (xx)
GE (1) GEP20094741B (xx)
GT (1) GT200600410A (xx)
HR (1) HRP20110749T1 (xx)
JO (1) JO2746B1 (xx)
MA (1) MA28504B1 (xx)
ME (1) ME01964B (xx)
MX (1) MXPA06010234A (xx)
MY (1) MY162318A (xx)
NO (1) NO338079B1 (xx)
NZ (1) NZ549727A (xx)
PE (1) PE20070613A1 (xx)
PL (1) PL1762238T3 (xx)
PT (1) PT1762238E (xx)
RS (1) RS52003B (xx)
SA (1) SA110320045B1 (xx)
SG (1) SG131029A1 (xx)
SI (1) SI1762238T1 (xx)
TW (1) TWI369980B (xx)
UA (1) UA83541C2 (xx)
UY (1) UY29776A1 (xx)
WO (1) WO2007028903A1 (xx)
ZA (1) ZA200607532B (xx)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CZ20013786A3 (cs) * 1999-04-29 2002-02-13 Merck Patent Gmbh Inhibitory glycinového ątěpicího systému jako moľná antipsychotika
CN100525761C (zh) * 1999-12-01 2009-08-12 Ucb公司 用于治疗cns疾病的吡咯烷乙酰胺衍生物或者其组合物
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JD GUELFI AND JR CALABRESE: "Efficacy and safety of the new antidepressant agomelatine in combination with a mood stabilizer in bipolar I patients with a major depressive episode" BIPOLAR DISORDERS, vol. 7, no. suppl.2, juin 2005 (2005-06), page 62, XP002378845 *

Also Published As

Publication number Publication date
US20070066689A1 (en) 2007-03-22
UY29776A1 (es) 2006-11-30
SG131029A1 (en) 2007-04-26
PL1762238T3 (pl) 2011-12-30
EP1762238A1 (fr) 2007-03-14
JP2007077149A (ja) 2007-03-29
PE20070613A1 (es) 2007-07-30
EA014381B1 (ru) 2010-10-29
AR055418A1 (es) 2007-08-22
MA28504B1 (fr) 2007-04-03
MXPA06010234A (es) 2007-03-08
AU2006209371A1 (en) 2007-03-29
SI1762238T1 (sl) 2011-10-28
FR2890563A1 (fr) 2007-03-16
UA83541C2 (uk) 2008-07-25
NO338079B1 (no) 2016-07-25
ATE519482T1 (de) 2011-08-15
NO20064049L (no) 2007-03-12
EP1762238B1 (fr) 2011-08-10
PT1762238E (pt) 2011-09-01
WO2007028903A1 (fr) 2007-03-15
CN1927194A (zh) 2007-03-14
GT200600410A (es) 2007-05-21
CY1112223T1 (el) 2015-12-09
AP2008004380A0 (en) 2008-04-30
ES2371482T3 (es) 2012-01-03
TW200800860A (en) 2008-01-01
RS52003B (en) 2012-04-30
JO2746B1 (en) 2014-03-15
SA110320045B1 (ar) 2014-01-29
CA2558764A1 (fr) 2007-03-09
KR20090056949A (ko) 2009-06-03
FR2890563B1 (fr) 2007-10-19
CA2558764C (fr) 2013-01-08
TWI369980B (en) 2012-08-11
AU2006209371B2 (en) 2012-02-02
ME01964B (me) 2012-04-30
BRPI0603767A (pt) 2007-08-14
DK1762238T3 (da) 2011-11-07
MY162318A (en) 2017-05-31
HRP20110749T1 (hr) 2011-11-30
EP2301527A1 (fr) 2011-03-30
US7902180B2 (en) 2011-03-08
ZA200607532B (en) 2008-05-28
KR20070029607A (ko) 2007-03-14
EA200601450A1 (ru) 2007-04-27
NZ549727A (en) 2008-03-28
GEP20094741B (en) 2009-07-27

Similar Documents

Publication Publication Date Title
HK1244267A1 (zh) 包含(r)-n-甲基納曲酮的藥物組合物
IL196168A0 (en) Biaryl compounds and pharmaceutical compositions containing the same
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
GB0413730D0 (en) A pharmaceutical composition and its use
IL179795A0 (en) A pharmaceutical composition and its use
EP1887008A4 (en) THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICAL APPLICATION THEREOF
IL215102A0 (en) A heteroaryl benzamide derivative and a pharmaceutical composition containing it
ZA200802947B (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
EP1932836A4 (en) ISOXAZOLINE-SUBSTITUTED BENZAMIDE COMPOUND AND AGENT FOR CONTROLLING HARMFUL ORGANISMS
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
IL187997A0 (en) Indane derivatives and pharmaceutical compositions containing the same
IL188732A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
ZA200701557B (en) Pharmaceutical compositions comprising diclofenac
IL188941A0 (en) Pyrazinolyguanidine derivatives and pharmaceutical compositions containing the same
IL186738A0 (en) Pyrizole derivatives and pharmaceutical compositions containing the same
PL1894567T3 (pl) Środki farmaceutyczne do podawania skojarzonego oraz ich zastosowanie
IL183919A0 (en) Triazolophthalazine derivatives and pharmaceutical compositions containing the same
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
PL1973423T3 (pl) Preparat zawierający kompozycję zawierającą polifenole i izomaltulozę
IL183986A0 (en) Pharmaceutical compounds and compositions
ZA200802436B (en) Composition comprising a NSAID and paracetamol
GB0516069D0 (en) Pharmaceutical and use thereof
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-SKIN COMPOSER
IL184996A0 (en) Dihydroimidazothiazole derivatives and pharmaceutical compositions containing the same